SENS Strangle Strategy

SENS (Senseonics Holdings, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.

Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners.

SENS (Senseonics Holdings, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $239.1M, a beta of 0.97 versus the broader market, a 52-week range of 4.79-12.58, average daily share volume of 824K, a public-listing history dating back to 2015, approximately 117 full-time employees. These structural characteristics shape how SENS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.97 places SENS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a strangle on SENS?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current SENS snapshot

As of June 30, 2026, spot at $5.63, ATM IV 90.00%, IV rank 21.49%, expected move 25.80%. The strangle on SENS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this strangle structure on SENS specifically: SENS IV at 90.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a SENS strangle, with a market-implied 1-standard-deviation move of approximately 25.80% (roughly $1.45 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SENS expiries trade a higher absolute premium for lower per-day decay. Position sizing on SENS should anchor to the underlying notional of $5.63 per share and to the trader's directional view on SENS stock.

SENS strangle setup

The SENS strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SENS near $5.63, the first option leg uses a $5.91 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SENS chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SENS shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$5.91	N/A
Buy 1	Put	$5.35	N/A

SENS strangle risk and reward

Net Premium / Debit: N/A
Max Profit (per contract): Unbounded
Max Loss (per contract): Unbounded
Breakeven(s): None on modeled curve
Risk / Reward Ratio: N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

SENS strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on SENS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on SENS

Strangles on SENS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SENS chain.

SENS thesis for this strangle

The market-implied 1-standard-deviation range for SENS extends from approximately $4.18 on the downside to $7.08 on the upside. A SENS long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current SENS IV rank near 21.49% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SENS at 90.00%. As a Healthcare name, SENS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SENS-specific events.

SENS strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SENS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SENS alongside the broader basket even when SENS-specific fundamentals are unchanged. Always rebuild the position from current SENS chain quotes before placing a trade.

Frequently asked questions

What is a strangle on SENS?: A strangle on SENS is the strangle strategy applied to SENS (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With SENS stock trading near $5.63, the strikes shown on this page are snapped to the nearest listed SENS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are SENS strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the SENS strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 90.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a SENS strangle?: The breakeven for the SENS strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SENS market-implied 1-standard-deviation expected move is approximately 25.80%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on SENS?: Strangles on SENS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the SENS chain.
How does current SENS implied volatility affect this strangle?: SENS ATM IV is at 90.00% with IV rank near 21.49%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.